−4.22 M EUR
317.79 K EUR
1.15 M
About PREDILIFE
Sector
Industry
CEO
Stéphane Ragusa
Website
Headquarters
Villejuif
Founded
2004
ISIN
FR0010169920
FIGI
BBG00MTXPT51
Predilife SA operates as a medical technology company. The firm develops and provides software that estimates the risk of breast cancer. It offers MammoRisk, which enables the risk of breast cancer to be evaluated. The company was founded by Stephane Ragusa in 2004 and is headquartered in Villejuif, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALPRE is 3.80 EUR — it has increased by 5.56% in the past 24 hours. Watch PREDILIFE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange PREDILIFE stocks are traded under the ticker ALPRE.
ALPRE stock has risen by 3.26% compared to the previous week, the month change is a 0.53% rise, over the last year PREDILIFE has showed a −38.71% decrease.
ALPRE reached its all-time high on May 2, 2024 with the price of 24.00 EUR, and its all-time low was 3.32 EUR and was reached on Oct 18, 2024. View more price dynamics on ALPRE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALPRE stock is 7.03% volatile and has beta coefficient of 0.04. Track PREDILIFE stock price on the chart and check out the list of the most volatile stocks — is PREDILIFE there?
Yes, you can track PREDILIFE financials in yearly and quarterly reports right on TradingView.
No, ALPRE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALPRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PREDILIFE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PREDILIFE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PREDILIFE stock shows the sell signal. See more of PREDILIFE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.